[非小细胞肺癌的现代个性化诊断和治疗]
Hauke Winter1, Martin Eichhorn2, Florian Eichhorn2
1Thoraxchirurgie, Thoraxklinik Heidelberg, Roentgenstraße 1, 69126, Heidelberg, Deutschland. hauke.winter@med.uni-heidelberg.de.
Chirurgie (Heidelberg, Germany)
|February 20, 2024
概括
早期非小细胞肺癌 (NSCLC) 可以通过分叶切除有效治疗. 未来的肺癌查和新辅助免疫疗法可能会推进外科治疗选择.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 肺部病理学 肺部病理学
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.7K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
